Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Novel Topical Cytokinin Improves Coarse Wrinkles and Skin Roughness Without Skin Irritation.

Garcia RL, McCullough JL, Reece B, Massino FJ.

J Drugs Dermatol. 2018 Jul 1;17(7):772-779.

PMID:
30005100
2.

Screen Exposure During Daily Routines and a Young Child's Risk for Having Social-Emotional Delay.

Raman S, Guerrero-Duby S, McCullough JL, Brown M, Ostrowski-Delahanty S, Langkamp D, Duby JC.

Clin Pediatr (Phila). 2017 Nov;56(13):1244-1253. doi: 10.1177/0009922816684600. Epub 2017 Feb 1.

PMID:
28952333
3.

The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic Properties.

Beattie DT, Armstrong SR, Vickery RG, Tsuruda PR, Campbell CB, Richardson C, McCullough JL, Daniels O, Kersey K, Li YP, Kim KH.

Front Pharmacol. 2011 May 30;2:25. doi: 10.3389/fphar.2011.00025. eCollection 2011.

4.

Medical students educate teens about skin cancer: what have we learned?

Kamell JM, Rietkerk W, Lam K, Phillips JM, Wu JJ, McCullough JL, Linden KG, Osann K.

J Cancer Educ. 2011 Mar;26(1):153-5. doi: 10.1007/s13187-010-0120-z.

5.

Botulinum toxin type A for the management of glabellar rhytids.

Tremaine AM, McCullough JL.

Clin Cosmet Investig Dermatol. 2010 Apr 7;3:15-23.

6.

A clinical study of topical Pyratine 6 for improving the appearance of photodamaged skin.

McCullough JL, Garcia RL, Reece B.

J Drugs Dermatol. 2008 Feb;7(2):131-5.

PMID:
18335649
7.

Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea.

Wu JJ, Weinstein GD, Kricorian GJ, Kormeili T, McCullough JL.

Clin Exp Dermatol. 2007 Nov;32(6):693-5. Epub 2007 Sep 14.

PMID:
17868391
8.

Prevention and treatment of skin aging.

McCullough JL, Kelly KM.

Ann N Y Acad Sci. 2006 May;1067:323-31. Review.

PMID:
16804006
9.

The 5-HT2B antagonist and 5-HT4 agonist activities of tegaserod in the anaesthetized rat.

McCullough JL, Armstrong SR, Hegde SS, Beattie DT.

Pharmacol Res. 2006 Apr;53(4):353-8. Epub 2006 Feb 21.

PMID:
16495076
10.

Measurement of 5-HT4 receptor-mediated esophageal responses by digital sonomicrometry in the anesthetized rat.

Armstrong SR, McCullough JL, Beattie DT.

J Pharmacol Toxicol Methods. 2006 May-Jun;53(3):198-205. Epub 2005 Sep 15.

PMID:
16168678
11.

A novel phosphatidylinositol manno-oligosaccharide (dPIM-8) from Gordonia sputi.

Furneaux RH, Landersjö CL, McCullough JL, Severn WB.

Carbohydr Res. 2005 Jul 4;340(9):1618-24.

PMID:
15907815
12.

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.

Beattie DT, Smith JA, Marquess D, Vickery RG, Armstrong SR, Pulido-Rios T, McCullough JL, Sandlund C, Richardson C, Mai N, Humphrey PP.

Br J Pharmacol. 2004 Nov;143(5):549-60. Epub 2004 Oct 4.

13.

Reducing wrinkles and other signs of aging.

McCullough JL, Shull T.

Dermatol Nurs. 2000 Dec;12(6):385-90; quiz 393-4. Review.

PMID:
11912824
14.

Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light.

Jeffes EW, McCullough JL, Weinstein GD, Kaplan R, Glazer SD, Taylor JR.

J Am Acad Dermatol. 2001 Jul;45(1):96-104.

PMID:
11423841
15.

Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study.

Jeffes EW, McCullough JL, Weinstein GD, Fergin PE, Nelson JS, Shull TF, Simpson KR, Bukaty LM, Hoffman WL, Fong NL.

Arch Dermatol. 1997 Jun;133(6):727-32.

PMID:
9197826
16.

Ablation of human nail by pulsed lasers.

Neev J, Nelson JS, Critelli M, McCullough JL, Cheung E, Carrasco WA, Rubenchik AM, Da Silva LB, Perry MD, Stuart BC.

Lasers Surg Med. 1997;21(2):186-92.

PMID:
9261796
17.

Photodynamic therapy using topically applied dihematoporphyrin ether in the treatment of cervical intraepithelial neoplasia.

Monk BJ, Brewer C, VanNostrand K, Berns MW, McCullough JL, Tadir Y, Manetta A.

Gynecol Oncol. 1997 Jan;64(1):70-5.

18.

Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid.

Fehr MK, Chapman CF, Krasieva T, Tromberg BJ, McCullough JL, Berns MW, Tadir Y.

Am J Obstet Gynecol. 1996 Mar;174(3):951-7.

19.

Elevated numbers of proliferating mononuclear cells in the peripheral blood of psoriatic patients correlate with disease severity.

Jeffes EW 3rd, Lee GC, Said S, Sabahi M, McCullough JL, Herrod R, Alzona CP, Linden KG, Soundararajan D, Edwards S, et al.

J Invest Dermatol. 1995 Dec;105(6):733-8.

20.

Effectiveness of topical therapy for psoriasis: results of a national survey.

Liem WH, McCullough JL, Weinstein GD.

Cutis. 1995 May;55(5):306-10.

PMID:
7614843
21.

Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate.

Jeffes EW 3rd, McCullough JL, Pittelkow MR, McCormick A, Almanzor J, Liu G, Dang M, Voss K, Voss J, Schlotzhauer A, et al.

J Invest Dermatol. 1995 Feb;104(2):183-8.

22.

Specificity of human keratinocyte X HeLa cell hybrid murine monoclonal antibodies.

Kwiatkowska B, McCullough JL, Weinstein GD, Stanbridge EJ.

Int J Dermatol. 1991 Dec;30(12):860-3.

PMID:
1816129
23.

Mid-infrared laser ablation of stratum corneum enhances in vitro percutaneous transport of drugs.

Nelson JS, McCullough JL, Glenn TC, Wright WH, Liaw LH, Jacques SL.

J Invest Dermatol. 1991 Nov;97(5):874-9.

24.

Free-tissue transfers for limb salvage utilizing in situ saphenous vein bypass conduit as the inflow.

Chowdary RP, Celani VJ, Goodreau JJ, McCullough JL, McDonald KM, Nicholas GG.

Plast Reconstr Surg. 1991 Mar;87(3):529-35.

PMID:
1998022
25.

Cytotoxic and immunologic effects of methotrexate in psoriasis.

Weinstein GD, Jeffes E, McCullough JL.

J Invest Dermatol. 1990 Nov;95(5 Suppl):49S-52S. Review.

26.

Cytotoxic and immunologic effects of methotrexate in psoriasis.

Weinstein GD, Jeffes E, McCullough JL.

J Invest Dermatol. 1990 Nov;95(5):49S-52S. Review.

PMID:
2230211
27.

Technical principles of direct innominate artery revascularization: a comparison of endarterectomy and bypass grafts.

Cherry KJ Jr, McCullough JL, Hallett JW Jr, Pairolero PC, Gloviczki P.

J Vasc Surg. 1989 May;9(5):718-23; discussion 723-4.

PMID:
2566694
28.

Skin photosensitivity and photodestruction of several potential photodynamic sensitizers.

Roberts WG, Smith KM, McCullough JL, Berns MW.

Photochem Photobiol. 1989 Apr;49(4):431-8.

PMID:
2727082
29.

Topical methotrexate therapy for psoriasis.

Weinstein GD, McCullough JL, Olsen E.

Arch Dermatol. 1989 Feb;125(2):227-30.

PMID:
2913960
30.

Topical cyclosporine: effects on allergic contact dermatitis in guinea pigs.

Biren CA, Barr RJ, Ganderup GS, Lemus LL, McCullough JL.

Contact Dermatitis. 1989 Jan;20(1):10-6.

PMID:
2914430
31.

Vasoactive pharmacologic responses of human skin xenografts in ciclosporin-treated rats.

Salm M, McCullough JL, Weinstein GD.

Skin Pharmacol. 1989;2(3):168-74.

PMID:
2627418
32.

Identification of differentiation-specific antigens in psoriatic versus normal skin using monoclonal antibodies.

McCullough JL, Weinstein GD, Ross P, Barr RJ, Stanbridge EJ.

Int J Dermatol. 1988 Nov;27(9):628-32.

PMID:
2466008
33.

Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice.

Nelson JS, McCullough JL, Berns MW.

J Natl Cancer Inst. 1988 Mar 2;80(1):56-60.

PMID:
2963136
34.
35.

The treatment of severe psoriasis. A national survey.

Peckham PE, Weinstein GD, McCullough JL.

Arch Dermatol. 1987 Oct;123(10):1303-7.

PMID:
3662561
36.
37.

Photosensitizers in dermatology.

McCullough JL, Weinstein GD, Douglas JL, Berns MW.

Photochem Photobiol. 1987 Jul;46(1):77-82.

PMID:
2956620
38.

A model of human melanoma in cyclosporine-immunosuppressed rats.

Goodman MM, McCullough JL, Biren CA, Barr RJ.

J Invest Dermatol. 1987 Feb;88(2):141-4.

39.

Growth kinetics of primary versus metastatic human melanoma xenografts in nude mice.

Ganderup GF, Newburger AE, McCullough JL.

J Invest Dermatol. 1986 Oct;87(4):537-9.

40.

Characterization of cutaneous phototoxicity induced by topical alpha-terthienyl and ultraviolet A radiation.

Rampone WM, McCullough JL, Weinstein GD, Towers GH, Berns MW, Abeysekera B.

J Invest Dermatol. 1986 Sep;87(3):354-7.

41.

Porphyrin sensitized phototherapy.

Berns MW, McCullough JL.

Arch Dermatol. 1986 Aug;122(8):871-4. No abstract available.

PMID:
2943229
42.

Prolonged viability of human skin xenografts in rats by cyclosporine.

Biren CA, Barr RJ, McCullough JL, Black KS, Hewitt CW.

J Invest Dermatol. 1986 Jun;86(6):611-4.

43.

Topical tritiated thymidine for epidermal growth fraction determination.

Klein JA, McCullough JL, Weinstein GD.

J Invest Dermatol. 1986 Apr;86(4):406-9.

44.

The costs of surgery for limb-threatening ischemia.

Mackey WC, McCullough JL, Conlon TP, Shepard AD, Deterling RA, Callow AD, O'Donnell TF.

Surgery. 1986 Jan;99(1):26-35.

PMID:
3079928
45.

Cell kinetic basis for pathophysiology of psoriasis.

Weinstein GD, McCullough JL, Ross PA.

J Invest Dermatol. 1985 Dec;85(6):579-83.

46.
47.

Evaluation of arterial prostheses in a baboon ex vivo shunt: the effect of graft material and flow on platelet deposition.

Eldrup-Jorgensen J, Mackey WC, Connolly RJ, McCullough JL, Ramberg K, Gavris V, O'Donnell TF, Callow AD.

Am J Surg. 1985 Aug;150(2):185-90.

PMID:
3161349
48.

The interaction of blood components with PDMS (polydimethylsiloxane) and LDPE (low-density polyethylene) in a baboon ex vivo arteriovenous shunt model.

Keough EM, Mackey WC, Connolly R, Foxall T, Ramberg-Laskaris K, McCullough JL, O'Donnell TF Jr, Callow AD.

J Biomed Mater Res. 1985 May-Jun;19(5):577-87.

PMID:
4066730
49.

Carotid endarterectomy after a completed stroke: reduction in long-term neurologic deterioration.

McCullough JL, Mentzer RM Jr, Harman PK, Kaiser DL, Kron IL, Crosby IK.

J Vasc Surg. 1985 Jan;2(1):7-14.

PMID:
3965761
50.

A baboon flow-regulated shunt for the study of small caliber vascular grafts.

Mackey WC, Keough EM, Connolly RJ, McCullough JL, Ramberg-Laskaris K, O'Donnell TF Jr, Foxall T, Callow AD.

J Surg Res. 1984 Aug;37(2):112-8.

PMID:
6235401

Supplemental Content

Loading ...
Support Center